1436-2813 < 1437-160X < 1437-7780

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by 1437-160X

Number of relevant bibliographic references: 102.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000048 (2020)	Hazan Karadeniz [Turquie] ; Asl Han Avano Lu Güler [Turquie] ; Nuh Atas [Turquie] ; Hasan Sat [Turquie] ; Reyhan Bilici Salman [Turquie] ; Hakan Babaoglu [Turquie] ; Abdurrahman Tufan [Turquie]	Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review.
000051 (2020)	Eun Hye Park [Corée du Sud] ; Eun Young Lee [Corée du Sud] ; Kichul Shin [Corée du Sud] ; Hyoun-Ah Kim [Corée du Sud]	Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
000054 (2020)	Rongda Li [République populaire de Chine] ; Qi Wan [République populaire de Chine] ; Pan Chen [République populaire de Chine] ; Shufen Mao [République populaire de Chine] ; Qiuju Wang [République populaire de Chine] ; Xiaoxin Li [République populaire de Chine] ; Yi Yang [République populaire de Chine] ; Li Dong [République populaire de Chine]	Tocilizumab treatment in Felty's syndrome.
000134 (2020)	Ayush Gupta [Inde] ; Narendra Kumar Bagri [Inde] ; Saroj Kumar Tripathy [Inde] ; Adarsh Barwad [Inde] ; Ravi Hari Phulware [Inde] ; Pankaj Hari [Inde]	Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.
000218 (2020)	Piero Ruscitti [Italie] ; Paola Cipriani [Italie] ; Vasiliki Liakouli [Italie] ; Daniela Iacono [Italie] ; Ilenia Pantano [Italie] ; Francesco Caso [Italie] ; Federico Perosa [Italie] ; Fabiola Atzeni [Italie] ; Francesco Paolo Cantatore [Italie] ; Raffaele Scarpa [Italie] ; Francesco Ciccia [Italie] ; Roberto Giacomelli [Italie]	Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
000296 (2020)	Mayan Gilboa [Israël] ; Gil Bornstein [Israël] ; Ilan Ben-Zvi [Israël] ; Chagai Grossman [Israël]	Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.
000311 (2020)	Durga Prasanna Misra [Inde] ; Sakir Ahmed [Inde] ; Vikas Agarwal [Inde]	Is biological therapy in systemic sclerosis the answer?
000333 (2020)	Michaela Koehm [Allemagne] ; Matthew J. Mcintosh [États-Unis] ; Michael W. Hofmann [Allemagne] ; Varghese Abraham [États-Unis] ; Cem Gabay [Suisse] ; Ernest H. Choy [Royaume-Uni] ; Arthur Kavanaugh [États-Unis] ; Harald Burkhardt [Allemagne] ; Frank Behrens [Allemagne]	Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies.
000434 (2020)	Rahime Koç [Turquie] ; Hafize Emine Sönmez [Turquie] ; Mustafa Çakan [Turquie] ; Erife Gül Karada [Turquie] ; Ay E Tanatar [Turquie] ; Figen Çakmak [Turquie] ; Nuray Aktay Ayaz [Turquie]	Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years' experience of a tertiary pediatric rheumatology center.
000466 (2020)	Tsvetoslav Georgiev	Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs
000469 (2020)	Jehun Song [Corée du Sud] ; Seongmin Kang [Corée du Sud] ; Seung Won Choi [Corée du Sud] ; Kwang Won Seo [Corée du Sud] ; Sunggun Lee [Corée du Sud] ; Min Wook So [Corée du Sud] ; Doo-Ho Lim [Corée du Sud]	Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs
000695 (2019)	Michitaro Hayakawa [Japon] ; Keisuke Izumi [Japon] ; Misako Higashida-Konishi [Japon] ; Mari Ushikubo [Japon] ; Masako Tsukamoto [Japon] ; Kumiko Akiya [Japon] ; Kazuhiro Araki [Japon] ; Hisaji Oshima [Japon]	Tocilizumab-induced psoriasis-like eruption resolved by shortening the dose interval in a patient with rheumatoid arthritis: a case-based review.
000700 (2019)	Martin Krusche [Allemagne] ; Nikolas Ruffer [Allemagne] ; Ina Kötter [Allemagne]	Tocilizumab treatment in refractory polyarteritis nodosa: a case report and review of the literature.
000892 (2019)	Kenji Oku [Japon] ; Tatsuya Atsumi [Japon]	Rheumatology practice in Japan: challenges and opportunities.
000921 (2019)	Tomoyuki Mutoh [Japon] ; Tomonori Ishii [Japon] ; Tsuyoshi Shirai [Japon] ; Kanae Akita [Japon] ; Yukiko Kamogawa [Japon] ; Yoko Fujita [Japon] ; Hiroko Sato [Japon] ; Yuko Shirota [Japon] ; Hiroshi Fujii [Japon] ; Hideo Harigae [Japon]	Refractory Takayasu arteritis successfully treated with rituximab: case-based review.
000B38 (2019)	Döndü Üsküdar Cansu [Turquie] ; Ezgi Demirta [Turquie] ; Neslihan Andiç [Turquie] ; Hava Üsküdar Teke [Turquie] ; Cengiz Korkmaz [Turquie]	Is it required to routinely check fibrinogen level in patients with rheumatic diseases on tocilizumab? Case-based review.
000C51 (2019)	Eleftherios Pelechas [Grèce] ; Alexandra Papoudou-Bai [Grèce] ; Paraskevi V. Voulgari [Grèce] ; Alexandros A. Drosos [Grèce]	Granuloma annulare development in a patient with rheumatoid arthritis treated with tocilizumab: case-based review.
000C94 (2019)	Francisco Airton Castro Rocha [Brésil] ; Joaquim Ivo Vasques Dantas Landim [Brésil] ; Marcela Gondim Aguiar [Brésil] ; João Pedro Emrich Accioly [Brésil] ; Carolina Noronha Lechiu [Brésil] ; Luiza Helena Acácio Costa [Brésil] ; Carlos Nobre Rabelo Júnior [Brésil] ; Leila Nascimento Da Rocha [Brésil] ; Hermano Alexandre Lima Rocha [Brésil]	Evaluation of disease activity in a low-income juvenile idiopathic arthritis cohort.
001199 (2018)	Matthew B. Carroll [États-Unis] ; Charles Haller [États-Unis] ; Christopher Smith [États-Unis]	Short-term application of tocilizumab during myocardial infarction (STAT-MI).
001201 (2018)	María Martín-L Pez [Espagne] ; Loreto Carmona [Espagne] ; Alejandro Balsa [Espagne] ; Jaime Calvo-Alén [Espagne] ; Raimon Sanmartí [Espagne] ; Jesús Tornero [Espagne] ; José Rosas [Espagne]	Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review.
001301 (2018)	Lisa Baganz [Allemagne] ; Adrian Richter [Allemagne] ; Jörn Kekow [Allemagne] ; Arnold Bussmann [Allemagne] ; Andreas Krause [Allemagne] ; Carsten Stille [Allemagne] ; Joachim Listing [Allemagne] ; Angela Zink [Allemagne] ; Anja Strangfeld [Allemagne]	Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "1437-160X" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "1437-160X" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1437-160X
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021